Cannabis Law Report

OCTOBER 22, 2021

The “Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” report provides comprehensive insights for about 25+ companies and 50+ pipeline drugs in Medical Marijuana – Cannabidiol pipeline landscape.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Puff Puff Post

DECEMBER 28, 2018

The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. CBD Oil For Autism: How Can Cannabis Help?

Treatment 76

Treatment Oil CBD Therapy 76

Veriheal

DECEMBER 4, 2023

At that time, illicit substances were perceived as a significant threat to both workplace productivity and safety. According to 2021 research from the National Institutes of Health (NIH) , 18.7% Do not attempt to self-diagnose or prescribe treatment based on the information provided.

Policy 117

Policy Safety Treatment Business 117

Veriheal

NOVEMBER 28, 2023

The inaccuracy of impairment detection not only puts road safety at risk but also exposes innocent drivers to potential legal consequences. It requires striking a balance between adjusting to societal changes and ensuring public safety. Notably, a 2021 study conducted by Johns Hopkins University raised these concerns.

THC 113

THC Safety Treatment Legalization 113

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.) 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 3, 2022

Below are some highlights of what happened in 2021. On June 22, 2021, Connecticut legalized recreational marijuana use by adults 21 years and older. On April 12, 2021, New Mexico saw the legalization of recreational marijuana. Now is no different. Jennifer Mora. Connecticut. New Mexico. New Jersey.

Law 52

Law Marijuana Policy Recreational 52

TheAnswerPage

NOVEMBER 23, 2021

Cancer is a qualifying condition for a medical marijuana recommendation in all of the US state medical marijuana programs. What are the most common reasons for breast cancer patients undergoing adjuvant and palliative radiation therapy to use medical marijuana products? ” Marco Meglio [link].

Chronic Pain 52

Chronic Pain Therapy Patients Safety 52

Canna Law Blog

DECEMBER 16, 2021

On Monday, November 13, 2021, New York Assemblyman Pat Burke introduced medical psilocybin legislation. Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Expansive List of Qualifying Medical Conditions.

Legislation 97

Legislation Treatment Therapy Conditions 97

Veriheal

NOVEMBER 10, 2020

The experiment will only last two years long and is set to start with the first prescription in March 2021. The list of qualifying conditions in which physicians will use a guide for those who may be prescribed medical cannabis in the experiment. . The procedures for importing, storing, distributing, and controlling medical cannabis.

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76

Cannabis Law Report

NOVEMBER 26, 2021

(NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended September 30, 2021. On September 30, 2021, Can-Fite had approximately $13.3 Fortified Balance Sheet.

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. California has long been a pioneer in the field of medical marijuana, and its MMJ laws have continued to evolve over the years.

Patients 52

Patients Law Cultivation Dispensary 52

Cannabis Law Report

AUGUST 22, 2021

Company has also initiated preclinical studies aimed at treating psychologic and neurologic conditions. 16, 2021 /CNW/ — PsyBio Therapeutics Corp. PsyBio’s intellectual property portfolio now includes seven pending provisionals and one pending non-provisional patent application. OXFORD, Ohio and COCONUT CREEK, Fla.,

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.

Business 105

Business Research and Development Environment Food 105

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

OCTOBER 18, 2021

DUBLIN–(BUSINESS WIRE)–The “Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. VSN16R is currently in phase II stage of development for the treatment of spasticity in people with multiple sclerosis.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Cannabis Law Report

OCTOBER 9, 2021

A coalition of Pennsylvania lawmakers introduced a bill this week that’s meant to promote research into the therapeutic potential of psilocybin mushrooms for mental health conditions such as post-traumatic stress disorder (PTSD)—the latest example of how the psychedelics reform movement is gaining momentum. Posted: July 26, 2021 12:18 PM.

Therapy 52

Therapy Clinical Trials Treatment Legislation 52

Dykema (Cannabis Law Blog)

APRIL 20, 2023

[iii] The Act was originally intended for patients with intractable epilepsy and was expanded in 2019 and 2021 to include other physical and mental illnesses (cancer, multiple sclerosis, post-traumatic stress disorder). [iv] Health & Safety Code § 487.001 et seq. [iv] Specifically, H.B. Code § 169.001 et seq. [vi] 1805, 88th Leg.,

Law 74

Law Chronic Pain Conditions Medicine 74

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Sapphire-Pricing-and-Timelines-v1.4. In addition, there is no cost for repeat prescriptions, making Sapphire the cheapest medical clinic in the country.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

DECEMBER 26, 2021

December 17, 2021 ·. – December 16, 2021) – Entheon Biomedical Corp. 63/283,051, titled “Detection of Therapeutic Psychedelic State,” as of November 23, 2021. 63/283,051, titled “Detection of Therapeutic Psychedelic State,” as of November 23, 2021. US Provisional Patent Filed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

OCTOBER 29, 2021

NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year. The primary endpoint of this Phase 1 trial was safety and tolerability. During the six months ended September 30, 2021, the Company raised approximately $4.1

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

The Cannigma

AUGUST 22, 2021

The idea is that the tampon is inserted vaginally as a way to apply cannabinoids to treat vaginal and abdominal pain caused by menstruation, endometriosis, and other gynecological conditions. The safety of CBD and other marijuana tampons may depend in part on where you live. More on that below.). Are CBD tampons safe?

THC 119

THC CBD Research and Development Conditions 119

The Cannigma

MARCH 7, 2022

CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Those enrolled in the study will receive 28 days of treatment and then be assessed by pain-rating scales.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

The Joint Blog

MARCH 21, 2021

CBD oil can be used in all sorts of ways, but it is most commonly associated with the treatment of various medical conditions. There is evidence out there to suggest that CBD oil can be used to treat the following conditions: Epilepsy. CBD Safety. Depression. Chronic pain. Cancer-related symptoms.

Safety 26

Safety CBD Oil Cannabinoids 26

Cannabis Law Report

SEPTEMBER 22, 2021

Pnina Fishman will present at the Benzinga Healthcare Small Cap Conference on September 29, 2021 and will join a panel discussion regarding medical cannabis. Date: Wednesday, September 29, 2021. Date: Wednesday, September 29, 2021. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S.

Clinical Trials 52

Clinical Trials Treatment Business Events 52

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The treatment takes up to three months to complete, and does not require ongoing medication. Despite the profoundly devastating effects of PTSD, few effective treatments are available.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

AUGUST 12, 2021

Czech Republic August 11 2021. On 22 July 2021, the Chamber of Deputies proposed a change to the government’s Act on pharmaceuticals aiming to improve the availability of drugs containing addictive substances. In addition, cannabis for medical use will be exported abroad under the same conditions as other addictive substances.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. What’s more, over the coming years psychedelics will continue to gain acceptance for treating these conditions which will also contribute to that market growth.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Cannabis Law Report

JANUARY 20, 2022

The request is intended for emergency access, meaning it must be made for treating a patient with a serious or life-threatening condition where conventional treatments either have failed, are unsuitable, or are not available in Canada. 2 Regulatory Impact Analysis Statement, SOR/2021-271, Canada Gazette Part II , Vol.

Access 52

Access Programs Treatment Therapy 52

Cannabis Law Report

AUGUST 17, 2021

Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Conference call and webcast to be held today at 4:30 p.m.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

FEBRUARY 17, 2022

WORCESTER – The Cannabis Control Commission (Commission) is alerting patients and consumers to its quarantine order (Order), issued October 18, 2021, mandating that ACK Natural, LLC, a colocated medical- and adult-use licensee, recall all products with unverifiable mycotoxin test results sold to its consumers and patients.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

AUGUST 18, 2021

As we previously reported , on February 22, 2021, New Jersey Governor Phil Murphy signed three separate cannabis reform bills into law ( NJ A21 , NJ A 1897 , and NJ A5342/NJ S3454 ), formally legalizing the use and possession of recreational marijuana in the Garden State. Other jurisdictions are catching up to the marijuana law frenzy.

Legislation 105

Legislation Legalization Marijuana Recreational 105

Cannabis Law Report

JUNE 16, 2021

Patients deserve more options, and to be assured of the safety and efficacy of their treatments; similarly, physicians deserve answers and are a critical partner in the development of this new therapeutic class,” says Erin Prosk , President of Santé. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JUNE 21, 2021

In the medical cannabis industry, mostly due to the plant’s long history of prohibition, there is a decided lack of data regarding the use and efficacy of cannabis as a treatment for a wide variety of indications. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JULY 8, 2021

A Swinburne study into the effects on medical cannabis on driving ability has received $358,980 in funding from the federal government’s Road Safety Innovation Fund. As medicinal cannabis becomes increasingly available, solutions to identify and reduce cannabis impaired driving are urgently needed to promote traffic safety.

Medicine 98

Medicine Research and Development Safety THC 98

Cannabis Law Report

OCTOBER 4, 2021

28 September 2021. As a result, the TGA had not evaluated these products for quality, safety or efficacy and the manufacturer had not obtained relevant approvals. Please speak with your doctor if you have any questions about medicinal cannabis for the possible treatment of your health condition.

Law 52

Law Treatment Medicine CBD 52

Cannabis Law Report

NOVEMBER 1, 2021

The TGA will be considering their position (once more) in December 2021, following the September 30th tabling of an independent report. November 2020 – April 2021. April 2021 – September 2021. The Application and Interim Decision. The Committee Delegate of the Secretary (i.e. The Independent Expert Panel.

Therapy 52

Therapy Medicine Environment Conditions 52